National Health Investors’ (NHI) Hold Rating Reaffirmed at Cantor Fitzgerald
National Health Investors (NYSE:NHI)‘s stock had its “hold” rating reaffirmed by analysts at Cantor Fitzgerald in a research note issued to investors on Thursday. They presently have a $80.00 target price on the real estate investment trust’s stock. Cantor Fitzgerald’s price objective would indicate a potential upside of 5.29% from the stock’s previous close.
The analysts wrote, “. We are lowering our 2019 outlook slightly, to reflect NHI’s amended lease with Holiday, but reiterating our $80 price target and Neutral rating. NHI reported in-line 3Q18 results and reaffirmed its full year 2018 guidance, but announced a lease amendment with Holiday (which accounts for 14% of revenue) that will cut the operator’s rent in 2019. M&A was limited, but NHI continued to fund $56 million of development/redevelopment commitments. The company’s relatively low leverage and strong lease coverage, despite Holiday’s issues, reflect NHI’s balance, and its primary reliance upon deal-making with its existing operators.””
A number of other analysts have also recently commented on the stock. Zacks Investment Research cut shares of National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, August 14th. Stifel Nicolaus set a $83.00 target price on shares of National Health Investors and gave the company a “buy” rating in a report on Tuesday, August 7th. SunTrust Banks restated a “hold” rating and set a $79.00 target price on shares of National Health Investors in a report on Wednesday, August 8th. They noted that the move was a valuation call. Finally, Wells Fargo & Co reiterated a “hold” rating on shares of National Health Investors in a research note on Tuesday, August 28th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $75.22.
National Health Investors (NYSE:NHI) last announced its earnings results on Tuesday, November 6th. The real estate investment trust reported $0.97 EPS for the quarter, missing the Zacks’ consensus estimate of $1.39 by ($0.42). National Health Investors had a net margin of 53.15% and a return on equity of 11.56%. The business had revenue of $74.92 million for the quarter, compared to the consensus estimate of $73.72 million. During the same quarter last year, the firm posted $1.37 EPS. The business’s quarterly revenue was up 5.0% on a year-over-year basis. As a group, analysts expect that National Health Investors will post 5.5 earnings per share for the current year.
Institutional investors have recently made changes to their positions in the stock. Truvestments Capital LLC bought a new position in National Health Investors in the 3rd quarter worth about $108,000. First Hawaiian Bank bought a new position in National Health Investors in the 3rd quarter worth about $162,000. Nissay Asset Management Corp Japan ADV bought a new position in National Health Investors in the 3rd quarter worth about $203,000. Zeke Capital Advisors LLC bought a new position in National Health Investors in the 2nd quarter worth about $201,000. Finally, MML Investors Services LLC bought a new position in National Health Investors in the 3rd quarter worth about $212,000. Institutional investors own 68.79% of the company’s stock.
About National Health Investors
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.